Literature DB >> 21464867

Squamous cell cancer of the esophagus: the forgotten one.

Lawrence Leichman1, Charles R Thomas.   

Abstract

Entities:  

Year:  2011        PMID： 21464867      PMCID： PMC3070285     

Source DB:  PubMed          Journal:  Gastrointest Cancer Res        ISSN： 1934-7820


× No keyword cloud information.
  11 in total

1.  A national cancer clinical trials system for the 21st century: reinvigorating the NCI Cooperative Group Program.

Authors:  John F Scoggins; Scott D Ramsey
Journal:  J Natl Cancer Inst       Date:  2010-08-03       Impact factor: 13.506

2.  The sociobiologic integrative model (SBIM): enhancing the integration of sociobehavioral, environmental, and biomolecular knowledge in urban health and disparities research.

Authors:  M Chris Gibbons; Malcolm Brock; Anthony J Alberg; Thomas Glass; Thomas A LaVeist; Stephen Baylin; David Levine; C Earl Fox
Journal:  J Urban Health       Date:  2007-03       Impact factor: 3.671

3.  Publication biases and phase II trials investigating anticancer targeted therapies.

Authors:  Nicolas Penel; Antoine Adenis
Journal:  Invest New Drugs       Date:  2008-10-18       Impact factor: 3.850

4.  Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus.

Authors:  D H Ilson; J Ajani; K Bhalla; A Forastiere; Y Huang; P Patel; L Martin; J Donegan; R Pazdur; C Reed; D P Kelsen
Journal:  J Clin Oncol       Date:  1998-05       Impact factor: 44.544

5.  Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus.

Authors:  Michael Stahl; Martin Stuschke; Nils Lehmann; Hans-Joachim Meyer; Martin K Walz; Siegfried Seeber; Bodo Klump; Wilfried Budach; Reinhard Teichmann; Marcus Schmitt; Gerd Schmitt; Claus Franke; Hansjochen Wilke
Journal:  J Clin Oncol       Date:  2005-04-01       Impact factor: 44.544

6.  Phase II Trial of Docetaxel and Carboplatin in Patients With Advanced Squamous Carcinoma of the Esophagus (E2298): A Trial of the Eastern Cooperative Oncology Group.

Authors:  Joanne F Rossman; Carla I Falkson; Ronghui Xu; Coenraad F Slabber; Bernard A Mason; Mary F Mulcahy; Al B Benson
Journal:  Gastrointest Cancer Res       Date:  2011-01

7.  Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age.

Authors:  Linda Morris Brown; Susan S Devesa; Wong-Ho Chow
Journal:  J Natl Cancer Inst       Date:  2008-08-11       Impact factor: 13.506

8.  Induction combination chemotherapy with docetaxel and carboplatin in advanced non-small-cell lung cancer.

Authors:  B Herse; H Dalichau; B Wörmann; B Hemmerlein; H Schmidberger; C F Hess; P Hannemann; C P Criée; W Hiddemann; F Griesinger
Journal:  Thorac Cardiovasc Surg       Date:  1998-10       Impact factor: 1.827

9.  Promoter methylation of HIN-1 in the progression to esophageal squamous cancer.

Authors:  Mingzhou Guo; Jingli Ren; Malcolm V Brock; James G Herman; Hetty E Carraway
Journal:  Epigenetics       Date:  2008-11-08       Impact factor: 4.528

10.  Cancer statistics, 2003.

Authors:  Ahmedin Jemal; Taylor Murray; Alicia Samuels; Asma Ghafoor; Elizabeth Ward; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2003 Jan-Feb       Impact factor: 508.702
View more
  3 in total

1.  Transhiatal vs. Transthoracic Esophagectomy: A NSQIP Analysis of Postoperative Outcomes and Risk Factors for Morbidity.

Authors:  Francisco Schlottmann; Paula D Strassle; Marco G Patti
Journal:  J Gastrointest Surg       Date:  2017-09-12       Impact factor: 3.452

2.  The Race-Specific Incidence of Esophageal Squamous Cell Carcinoma in Individuals With Exposure to Tobacco and Alcohol.

Authors:  Anoop Prabhu; Kenneth Obi; David Lieberman; Joel H Rubenstein
Journal:  Am J Gastroenterol       Date:  2016-08-30       Impact factor: 10.864

3.  Prevalence of Squamous Cell Carcinoma of the Esophagus in a Single Tertiary Center of South Africa: A Cross Sectional Analytic Study.

Authors:  Mpho Kgomo; Ali A Elnagar; Jaco Nagel; Taole Mokoena
Journal:  J Public Health Afr       Date:  2017-08-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.